The signature event in Cambridge Healthtech Institute's Biomarker Series, the Ninth Annual Biomarkers & Diagnostics World Congress 2013 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting will be held May 6-8, 2013 in Philadelphia, Pennsylvania and brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers-making the Congress a perfect meeting place to share experiences, foster collaborations across industry and academia, and evaluate emerging technologies.
The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers. Now in its ninth year, the Biomarkers & Diagnostics World Congress is the leading annual meeting dedicated to biomarker and diagnostics research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.
The program is expanded this year to include cutting-edge coverage of diagnostics, including clinical assay development, companion diagnostics, regulatory compliance, tissue diagnostics, and exosome biomarkers. The World Congress will continue offering a comprehensive coverage of biomarkers in drug development, including translational biomarkers, patient selection, drug-diagnostic co-development, and cancer drug resistance. The two Executive Summits are designed to bring together the drug development and diagnostics leaders to brainstorm strategies for Rx-Dx co-development.
- Nicholas C. Dracopoli – VP Janssen R&D, Johnson & Johnson
- Khusru Asadullah – VP, Head, Global Biomarkers Bayer
- Yoshi Oda – President, Biomarkers & Personalized Medicine, Eisai
- Eric Lai – SVP, Head, Pharmacogenomics, Takeda
- David Wholley – Director, Biomarkers Consortium
Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by March 29, 2013.
Register online, or by phone, fax or mail. Please indicate that you would like to present a poster. Once your registration has been fully processed, we will send an email with a unique link and instructions for submitting your abstract using our online abstract submission tool. Please see below for more information.
Reasons you should present your research poster at this conference:
- Your poster will be exposed to our international delegation
- Receive $50 off your registration
- Your poster abstract will be published in our conference materials
- Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutes